Central activation, muscle performance, and physical function in men infected with human immunodeficiency virus

Muscle and Nerve

Volumn 36, Issue 3, 2007, Pages 374-383

  Scott, Wayne B ^a   Oursler, Krisann K ^a,b   Katzel, Leslie I ^a,b   Ryan, Alice S ^a,b   Russ, David W ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

Central activation; Electrical stimulation; HIV infection; Muscle cross sectional area

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AEROBIC CAPACITY; ANKLE; ANKLE DORSIFLEXOR; ARTICLE; CD4 LYMPHOCYTE COUNT; CENTRAL ACTIVATION RATIO; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ELECTROSTIMULATION; EXTENSOR MUSCLE; FUNCTIONAL STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KNEE; MALE; MAXIMUM VOLUNTARY CONTRACTION; MOTOR PERFORMANCE; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE DISEASE; MUSCLE FUNCTION; MUSCLE WEAKNESS; NEUROMUSCULAR FUNCTION; PARAMETER; PHYSICAL CAPACITY; PRIORITY JOURNAL; TREADMILL EXERCISE; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANAEROBIC THRESHOLD; ELECTROPHYSIOLOGY; HIV-1; HUMANS; KNEE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR ATROPHY; QUADRICEPS MUSCLE;

EID: 34548258351     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20832     Document Type: Article

References (50)

1. American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription, 7th ed. Baltimore: Lippincott, Williams & Wilkins; 2006.
2. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;161:111-117.
3. Authier FJ, Chariot P, Gherardi RK. Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART). Muscle Nerve 2005;32:247-260.
4. Berger JR, Espinosa PS, Kissel J. Brachial amyotrophic diplegia in a patient with human immunodeficiency virus infection: widening the spectrum of motor neuron diseases occurring with the human immunodeficiency virus. Arch Neurol 2005;62:817-823.
5. Binder-Macleod SA, Russ DW. Effects of activation frequency and force on low-frequency fatigue in human skeletal muscle. J Appl Physiol 1999;86:1337-1346.
6. Brown SP, Miller WC, Eason JM. Exercise physiology: basis of human movement in health and disease. Baltimore: Lippincott, Williams & Wilkins; 2006. p 98-124.
7. Cade WT, Fantry LE, Nabar SR, Keyser RE. Decreased peak arteriovenous oxygen difference during treadmill exercise testing in individuals infected with the human immunodeficiency virus. Arch Phys Med Rehabil 2003;84:1595-1603.
8. 2 in individuals with HIV taking and not taking HAART. Med Sci Sports Exerc 2003;35:1I08-1117.
9. Cade WT, Fantry LE, Nabar SR, Shaw DK, Keyser RE. Impaired oxygen on-kinetics in persons with human immunodeficiency virus are not due to highly active antiretroviral therapy. Arch Phys Med Rehabil 2003;84:1831-1838.
10. Connelly DM, Rice CL, Roos MR, Vandervoort AA. Motor unit firing rates and contractile properties in tibialis anterior of young and old men. J Appl Physiol 1999;87:843-852.
11. Crystal S, Fleishman JA, Hays RD, Shapiro MF, Bozzette SA. Physical and role functioning among persons with HIV. Results from a nationally representative survey. Medical Care 2000;38:1210-1223.
12. Enright PL, Sherrill DL. Reference equations for the 6-min walk in healthy adults. Am J Respir Crit Care Med 1998;158:1384-1387.
13. Estanislao L, Thomas D, Simpson D. HIV neuromuscular disease and mitochondrial function. Mitochondrion 2004;4:131-139.
14. Fitzgerald GK, Piva SR, Irrgang JJ, Bouzubar F, Starz TW. Quadriceps activation failure as a moderator of the relationship between quadriceps strength and physical function in individuals with knee osteoarthritis. Arthritis Rheum 2004;51:40-48.
15. Franklin BA, Gordon S, Timmis GC. Fundamentals of exercise physiology: implications for exercise testing and prescription. In: Franklin BA, Gordon S, Timmis GC, editors. Exercise in modern medicine. Baltimore: Williams and Wilkins; 1989. p 8.
16. Goodpaster BH, Kelley DE, Leland Thaete F, He J, Ross R. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol 2000;89:104-110.
17. Grinspoon S, Corcoran C, Rosenthal D, Stanley T, Parlman K, Costello M, et al. Quantitative assessment of cross-sectional muscle area, functional status, and muscle strength in men with the acquired immunodeficiency syndrome wasting syndrome. J Clin Endocrinol Metab 1999;84:201-206.
18. Grinspoon S, Mulligan K. Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis 2003;36:S69-S78.
19. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-923.
20. Herzog W. Biomaterials: muscle. In: Nigg M, Herzog W, editors. Biomechanics of the musculo-skeletal system, Vol. 2. New York: John Wiley & Sons; 1995. p 168-187.
21. Houmard JA, Weidner ML, Gavigan GL, Tyndall GL, Hickey MS, Alshami A. Fiber type and citrate synthase activity in the human gastrocnemius and vastus lateralis with aging. J Appl Physiol 1998;85:1337-1341.
22. Kent-Braun JA, Le Blanc R. Quantitation of central activation failure during maximal voluntary contractions in humans. Muscle Nerve 1996;19:861-869.
23. Kent-Braun JA, Miller RG. Central fatigue during isometric exercise in amyotrophic lateral sclerosis. Muscle Nerve 2000;23:909-914.
24. Kent-Braun JA, Ng AV, Doyle JW, Towse TF. Human skeletal muscle responses vary with age and gender during fatigue due to incremental isometric exercise. J Appl Physiol 2002;93:1813-1823.
25. Lanza IR, Russ DW, Kent-Braun JA. Age-related enhancement of fatigue resistance is evident in men during both isometric and dynamic tasks. J Appl Physiol 2004;97:967-975.
26. Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di lorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 2003;95:1851-1860.
27. Lewek MD, Rudolph KS, Snyder-Mackler L. Quadriceps femoris muscle weakness and activation failure in patients with symptomatic knee osteoarthritis. J Orthop Res 2004;22:110-115.
28. Lindle RS, Metter EJ, Lynch NA, Fleg JL, Fozard JL, Tobin J, et al. Age and gender comparisons of muscle strength in 654 women and men aged 20-93 yr. J Appl Physiol 1997;83:1581-1587.
29. Mangili A, Murman DH, Zampini AM, Wanke CA. Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort. Clin Infect Dis 2006;42:836-842.
30. McComas AJ, Galea V, de Bruin H. Motor unit populations in healthy and diseased muscles. Phys Ther 1993;73:868-877.
31. Mizner RL, Petterson SC, Stevens JE, Vandenborne K, Snyder-Mackler L. Early quadriceps strength loss after total knee arthroplasty. The contributions of muscle atrophy and failure of voluntary muscle activation. J Bone Joint Surg Am 2005;87:1047-1053.
32. Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 2006;61:72-77.
33. Ng AV, Miller RG, Gelinas D, Kent-Braun JA. Functional relationships of central and peripheral muscle alterations in multiple sclerosis. Muscle Nerve 2004;29:843-852.
34. Oursler KK, Sorkin JD, Smith B, Katzel LI. Reduced aerobic capacity and physical functioning in older HIV-infected men. AIDS Res Hum Retroviruses 2006;22:1113-1121.
35. Pothoff G, Wassermann K, Ostmann H. Impairment of exercise capacity in various groups of HIV-infected patients. Respiration 1994;61:80-85.
36. Roubenoff R. Acquired immunodeficiency syndrome wasting, functional performance, and quality of life. Am J Manag Care 2000;6:1003-1016.
37. Russ DW, Kent-Braun JA. Sex differences in human skeletal muscle fatigue are eliminated under ischemic conditions. J Appl Physiol 2003;94:2414-2422.
38. Russ DW, Lanza IR, Rothman D, Kent-Braun JA. Sex differences in glycolysis during brief, intense isometric contractions. Muscle Nerve 2005;32:647-655.
39. Stackhouse SK, Binder-Macleod SA, Lee SC. Voluntary muscle activation, contractile properties, and fatigability in children with and without cerebral palsy. Muscle Nerve 2005;31:594-601.
40. Stackhouse SK, Dean JC, Lee SC, Binder-Macleod SA. Measurement of central activation failure of the quadriceps femoris in healthy adults. Muscle Nerve 2000;23:1706-1712.
41. Stackhouse SK, Stevens JE, Johnson CD, Snyder-Mackler L, Binder-Macleod SA. Predictability of maximum voluntary isometric knee extension force from submaximal contractions in older adults. Muscle Nerve 2003;27:40-45.
42. Stackhouse SK, Stevens JE, Lee SC, Pearce KM, Snyder-Mackler L, Binder-Macleod SA. Maximum voluntary activation in nonfatigued and fatigued muscle of young and elderly individuals. Phys Ther 2001;81:1102-1109.
43. Stevens JE, Mizner RL, Snyder-Mackler L. Quadriceps strength and volitional activation before and after total knee arthroplasty for osteoarthritis. J Orthop Res 2003;21:775-779.
44. Stevens JE, Stackhouse SK, Binder-Macleod SA, Snyder-Mackler L. Are voluntary muscle activation deficits in older adults meaningful? Muscle Nerve 2003;27:99-101.
45. Stringer WW. Mechanisms of exercise limitation in HIV+ individuals. Med Sci Sports Exerc 1999;31:973-979.
46. Verma A. Epidemiology and clinical features of HIV-1 associated neuropathies. Peripher Nerv Syst 2000;6:8-13.
47. Verma A, Berger JR. ALS syndrome in patients with HIV-1 infection. J Neurol Sci 2006;240:59-64.
48. Verma RK, Ziegler DK, Kepes JJ. HIV-related neuromuscular syndrome simulating motor neuron disease. Neurology 1990;40:544-546.
49. Wanke CA, Silva M, Knox TA, Forrester J, Speigelman D, Gorbach SL. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 2000;31:803-805.
50. Wulff EA, Wang AK, Simpson DM. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs 2000;59:1251-1260.